June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Global approaches to dry eye diagnosis
Author Affiliations & Notes
  • James S. Wolffsohn
    Optometry and Vision Sciences, Aston University, Birmingham, United Kingdom
  • Jennifer P Craig
    Ophthalmology, The University of Auckland, Auckland, New Zealand
    Optometry and Vision Sciences, Aston University, Birmingham, United Kingdom
  • Lyndon William Jones
    Centre for Ocular Research & Education (CORE), School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada
  • Sonia Trave-Huarte
    Optometry and Vision Sciences, Aston University, Birmingham, United Kingdom
  • Michael TM Wang
    Ophthalmology, The University of Auckland, Auckland, New Zealand
  • Footnotes
    Commercial Relationships   James Wolffsohn, Alcon (R), Allergan (R), Atia Vision (C), Contamac (C), CooperVision (C), Essilor (C), Johnson & Johnson (R), Novartis (C), Rayner (C), Thea Pharmaceuticals (C); Jennifer Craig, Alcon (R), Azura Ophthalmics (C), E-Swin (R), E-Swin (C), Manuka Health NZ (R), Novartis (C), Théa Pharmaceuticals (R), Théa Pharmaceuticals (C); Lyndon Jones, Alcon (C), Alcon (R), Allergan (R), Contamac (R), CooperViison (R), CooperVision (C), GL Chemtec (R), Inflamax Research (R), Johnson & Johnson Vision (C), Johnson & Johnson Vision (R), Menicon (R), Nature's Way (R), Novaritis (R), Novartis (C), Ophtecs (C), PS Therapy (R), Santen (R), Shire (R), SightGlass (R), Visioneering (R); Sonia Trave-Huarte, None; Michael Wang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 117. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      James S. Wolffsohn, Jennifer P Craig, Lyndon William Jones, Sonia Trave-Huarte, Michael TM Wang; Global approaches to dry eye diagnosis. Invest. Ophthalmol. Vis. Sci. 2020;61(7):117.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dry eye is a chronic and often debilitating disease, but understanding the prevalence and the effectiveness of management is hampered by differences in diagnosis and subclassification. This cross-sectional survey of eye care practitioners across the world aimed to identify the current approaches to dry eye diagnosis.

Methods : A Survey Monkey questionnaire was developed in consultation with dry eye specialists. Questions sought to determine the tests practitioners consider essential in the diagnosis of dry eye. Which aid the diagnosis? Which aid the subclassification into evaporative or aqueous deficient dry eye? Descriptive statistics were applied.

Results : 1,139 responses were received from 51 countries, 38% from ophthalmologists and 58% from optometrists, with a median of 11-15years of experience. The main tests reported as critical for a diagnosis of dry eye were verbal symptoms (69%), fluorescein breakup time (67%) and corneal staining (64%). In addition, reports of visual disturbance (57%), symptomology results from a validated questionnaire (48%), ocular redness (54%) and blink/lid closure analysis (54%) were commonly used to aid diagnosis. A median of 7 tests were deemed essential to diagnose dry eye (range 0-28). Tests that proved popular for differentiating dry eye subtypes were Schirmer/Phenol red thread test (32%), meibomian gland expression (32%) and orifice examination (32%) and blink/lid closure analysis (32%); use of verbal (38%) and questionnaire (30%) symptomatology, fluorescein breakup time (39%) and corneal staining (37%), for this purpose, were also noted.

Conclusions : In 2018 when the data were collected, dry eye disease diagnosis among practitioners was not standardised and there was little agreement on subclassification to inform the optimal treatment strategy. Future studies will determine whether recent global consensus reports and position papers unify diagnosis of the disease to improve the quality of epidemiological and treatment efficacy data.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×